Medicare Enrolled
Dr. Ronald Villanueva, MD
Endocrinology · Lakewood, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Villanueva from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Villanueva?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Villanueva
Dr. Ronald Villanueva is an endocrinology specialist in Lakewood, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Villanueva performed 4,814 Medicare services across 2,674 unique beneficiaries.
Between the years covered by Open Payments, Dr. Villanueva received a total of $280,002 from 67 pharmaceutical and/or device companies across 1595 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Villanueva is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 13% volume in NJ
$280,002 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,814
Medicare services
Top 13% in NJ for endocrinology
2,674
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~241 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,568 | $143 | $280 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
1,417 | $3 | $10 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
716 | $28 | $53 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
610 | $101 | $199 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
138 | $134 | $258 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
105 | $107 | $201 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
87 | $128 | $265 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
60 | $84 | $175 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
56 | $55 | $98 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
34 | $78 | $142 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $62 | $157 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$280,002
Total received (2018-2024)
Avg $40,000/year across 7 years
Top 2% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
1,595
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$263,323 (94.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,909 (5.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,770 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$32,020
2023
$6,342
2022
$24,492
2021
$41,926
2020
$37,118
2019
$60,561
2018
$77,541
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$28,093
Novo Nordisk Inc
$409
AstraZeneca Pharmaceuticals LP
$371
Dexcom, Inc.
$357
Amneal Pharmaceuticals LLC
$339
Boehringer Ingelheim Pharmaceuticals, Inc.
$272
Ascensia Diabetes Care Us Inc.
$227
Medtronic, Inc.
$204
Tandem Diabetes Care, Inc.
$199
Corcept Therapeutics
$199
Abbott Laboratories
$182
Bayer Healthcare Pharmaceuticals Inc.
$169
SANOFI-AVENTIS U.S. LLC
$157
ABBVIE INC.
$115
Chiesi USA, Inc.
$99
Esperion Therapeutics, Inc.
$82
PFIZER INC.
$58
Madrigal Pharmaceuticals
$50
Alexion Pharmaceuticals, Inc.
$50
Insulet Corporation
$48
Kyowa Kirin, Inc.
$47
OPKO Pharmaceuticals, LLC
$46
Antares Pharma, Inc.
$45
Radius Health, Inc.
$41
Verity Pharmaceuticals Inc.
$31
Xeris Pharmaceuticals, Inc.
$30
CeQur Corporation
$29
Novartis Pharmaceuticals Corporation
$27
Amgen Inc.
$17
Intra-Sana Laboratories
$16
Acella Pharmaceuticals, LLC
$13
Top 3 companies account for 90.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$159,390
SANOFI-AVENTIS U.S. LLC
$40,309
Lilly USA, LLC
$35,416
Boehringer Ingelheim Pharmaceuticals, Inc.
$22,751
AbbVie, Inc.
$6,171
Novo Nordisk Inc
$3,151
AbbVie Inc.
$2,994
Amneal Pharmaceuticals LLC
$1,109
Dexcom, Inc.
$735
Abbott Laboratories
$723
Medtronic, Inc.
$604
Bayer Healthcare Pharmaceuticals Inc.
$494
Ascensia Diabetes Care Us Inc.
$484
Intuity Medical Inc
$422
Corcept Therapeutics
$365
Tandem Diabetes Care, Inc.
$324
MannKind Corporation
$294
Insulet Corporation
$265
Medtronic MiniMed, Inc.
$237
Antares Pharma, Inc.
$209
PFIZER INC.
$197
Merck Sharp & Dohme Corporation
$195
Bayer HealthCare Pharmaceuticals Inc.
$177
Mannkind Corporation
$172
Kowa Pharmaceuticals America, Inc.
$169
OPKO Pharmaceuticals, LLC
$164
Radius Health, Inc.
$163
DEXCOM, INC.
$162
Horizon Therapeutics plc
$141
Xeris Pharmaceuticals, Inc.
$138
Amarin Pharma Inc.
$132
ABBVIE INC.
$115
VIVUS, Inc.
$112
Chiesi USA, Inc.
$99
Amgen Inc.
$96
Alexion Pharmaceuticals, Inc.
$93
Valeritas, Inc.
$86
IBSA Pharma Inc.
$82
Esperion Therapeutics, Inc.
$82
Janssen Pharmaceuticals, Inc
$82
Becton, Dickinson and Company
$76
GENZYME CORPORATION
$71
CeQur Corporation
$67
EISAI INC.
$64
Kyowa Kirin, Inc.
$63
Clarus Therapeutics Inc.
$57
Madrigal Pharmaceuticals
$50
Aytu BioScience, Inc
$50
Novartis Pharmaceuticals Corporation
$39
Senseonics, Incorporated
$38
RECORDATI_RARE_DISEASES_INC.
$34
Verity Pharmaceuticals Inc.
$31
LifeScan, Inc.
$24
Currax Pharmaceuticals LLC
$24
Gemini Laboratories, LLC
$24
Supernus Pharmaceuticals, Inc.
$22
Nalpropion Pharmaceuticals LLC
$17
Amryt Pharma Holdings Ltd
$17
Companion Medical, Inc.
$17
Intra-Sana Laboratories
$16
Rhythm Pharmaceuticals, Inc.
$15
Endo Pharmaceuticals Inc.
$15
Eisai Inc.
$14
Regeneron Healthcare Solutions, Inc.
$14
Ultragenyx Pharmaceutical Inc.
$14
Acella Pharmaceuticals, LLC
$13
Shire North American Group Inc
$12
Top 3 companies account for 84.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BD Ultra-Fine · BYDUREON · Belviq · CONTRAVE · CeQur Simplicity · Corlanor · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LOKELMA · Lenvima · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 630G · Minimed 670G System · NASCOBAL · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Natesto · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnipod · OneTouch · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · QULIPTA · RAYALDEE · RELTONE 200 MG · RESMETIROM · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XYOSTED · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for endocrinology in NJ.
Geographic Context
Endocrinologists within 10 mi
47
Per 100K population
7.3
County median income
$86,411
Nearest hospital
MONMOUTH MEDICAL CENTER-SOUTHERN CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Villanueva is a clinical cardiology specialist, with above-average Medicare volume (top 13% in NJ), with speaking/promotional industry engagement in the top 2% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Villanueva experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Villanueva performed 1,568 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Villanueva receive payments from pharmaceutical companies?
Yes. Dr. Villanueva received a total of $280,002 from 67 companies across 1,595 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Villanueva's costs compare to other endocrinologists in Lakewood?
Dr. Villanueva's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Villanueva) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Lakewood
Browse endocrinologists in Lakewood ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NJ
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NJ
Which NJ endocrinologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology